Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by jonnieboyon Nov 04, 2022 7:55pm
246 Views
Post# 35074804

RE:RE:RE:RE:RE:RE:RE:RE: I wonder what that portends after we get through the ...?

RE:RE:RE:RE:RE:RE:RE:RE: I wonder what that portends after we get through the ...?You guys are getting a little to touchy feely I hope you are not all in the same room. Bottom line we are under .40 despite all of the good news, on the downside Kellum"s contract coming up, Baxters investment was chump change and we have more shares being issued. We will have sucess but not at the numbers  mentioned in previous posts.        Regards  jonnieby


And am the only one that had to look up Portend ?



<< Previous
Bullboard Posts
Next >>